A Burton-based firm has become the latest company to progress to be granted Home Office approval to cultivate, process, and pack medicinal cannabis ready for sale to the pharmaceutical market.
The Home Office license will allow Dalgety, based in Ryknield House, Alrewas, to begin commercial cultivation and distribution of its product, which follows its inspection from the UK Medicines and Healthcare products Regulatory Agency (MHRA).
James Leavesley, chief operating officer at Dalgety, said: “The granting of this license after three years of investment and development means we now join the limited few that are at the forefront of this burgeoning market.
“The opportunities are substantial, not just for the businesses and investors harnessing the economic potential of the industry, but for patients that cannot access the high-quality GMP-approved cannabis that Dalgety can provide.”
Read more at staffordshire-live.co.uk
